---
title: "EU grants Merck Animal Health marketing authorization for Nobivac NXT HCPChFeLV cat vaccine"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/294500247.md"
description: "The European Commission has granted marketing authorization for Merck Animal Health Ventures' NOBIVAC NXT HCPChFeLV cat vaccine. This product protects against five feline infectious diseases, including FeLV, offering immunity for up to three years with a one-week onset. The authorization follows a positive opinion from the European Medicines Agency's Committee for Medicinal Products for Veterinary Use issued on April 16, 2026."
datetime: "2026-07-31T10:47:27.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/294500247.md)
  - [en](https://longbridge.com/en/news/294500247.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/294500247.md)
generator: "portal-rs"
---

# EU grants Merck Animal Health marketing authorization for Nobivac NXT HCPChFeLV cat vaccine

-   European Commission granted marketing authorization for Merck Animal Health Ventures’ NOBIVAC NXT HCPChFeLV cat vaccine. \* Product targets five feline infectious diseases, including FeLV, with one-week onset and up to three years of immunity. \* Authorization follows a positive European Medicines Agency CVMP opinion issued on April 16, 2026. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Merck Animal Health Ventures published the original content used to generate this news brief on July 31, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

### Related Stocks

- [MRK.US](https://longbridge.com/en/quote/MRK.US.md)

## Related News & Research

- [Braun Stacey Associates Inc. Has $35.07 Million Stock Position in Merck & Co., Inc. $MRK](https://longbridge.com/en/news/297397633.md)
- [Key facts: Merck (MRK) up on vaccine; policy may hit M-M-R II, ProQuad](https://longbridge.com/en/news/296749142.md)
- [06:56 ETHow travelers can support wild animals rather than exploit them](https://longbridge.com/en/news/297901620.md)
- [Oracle may be next in EU software licensing hot seat following SAP deal](https://longbridge.com/en/news/298219347.md)
- [Stronger Q2 Results And Raised 2026 Outlook Could Be A Game Changer For IDEXX Laboratories (IDXX)](https://longbridge.com/en/news/298111178.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**